Oberarzt | Uniklinik Münster | Germany
Short Bio 📜
Dr. Mazen A. Juratli is an esteemed Assistant Professor and Senior Consultant Surgeon specializing in General, Visceral, and Transplant Surgery. He is an expert in upper gastrointestinal (GI) tumors, reflux surgery and peritoneal carcinomatosis. Currently, Dr. Juratli serves at the University Hospital of Muenster in Germany, where he leads the Stomach Cancer, Chirurgie and Peritoneal Carcinomatosis Surgical Center and is the Deputy Head of the Esophagus Cancer Center. His dedication to both clinical practice and research in surgical oncology is aimed at advancing medical science and enhancing patient care.
Profile
SCOPUS
Education 🎓
Dr. Juratli’s extensive educational background includes a Ph.D. in Interdisciplinary Biomedical Science from the University of Arkansas for Medical Sciences (UAMS) and a Doctor of Medicine (Dr. med.) from Philipps University, Marburg, Germany. His medical education and research training have laid a strong foundation for his distinguished career in surgical oncology and molecular genetics.
Experience 🏥
With over a decade of experience, Dr. Juratli has held various significant roles, including Senior Consultant Surgeon at the University Hospital of Muenster, Germany, and Consultant Surgeon at both the University Hospital of Muenster and University Hospital Frankfurt. His professional journey is marked by a steadfast commitment to excellence in surgery and patient care, coupled with a robust involvement in academic and research activities.
Research Interests 🔬
Dr. Juratli’s research focuses primarily on cancer research, liquid biopsy, and the molecular genetics of solid tumors. He is particularly interested in molecular biomarkers, such as circulating tumor and stem cells, exosomes, and ctDNA, and their implications for prognosis and therapy. His work leverages next-generation sequencing and big data analysis to explore novel diagnostic and therapeutic avenues in oncology.
Awards 🏆
Dr. Juratli’s contributions to medical science have been recognized with numerous awards and grants. These include the Industrial Grant Funding from Johnson & Johnson for surgical smoke exposure investigation, the German Society for General and Visceral Surgery Travel Award, and several abstract prizes for his groundbreaking research on tumor markers and extracellular vesicles. His accolades underscore his impact and innovation in the field of surgical oncology.
Publications 📚
Dr. Juratli has an impressive portfolio of peer-reviewed publications that contribute significantly to the field of surgical oncology and molecular diagnostics. Here are some highlights:
- Robotic-Assisted Esophagectomy with Total Mesoesophageal Excision Enhances R0-Resection in Patients with Esophageal Cancer – a single-center experience. Surgery, 2024.
- Validation of the IWATE Criteria in Robotic-Assisted Liver Resections. J Clin Med, 2024.
- Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma. Sci Rep, 2024.
- Proteomic analysis of decellularized mice liver and kidney extracellular matrices. J Biol Eng, 2024.
- Surgical Techniques and Related Perioperative Outcomes After Robot-assisted Minimally Invasive Gastrectomy (RAMIG). Ann Surg, 2023.